Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:57 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 3,637,718 7.920% |
189,197 (+5.49%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
RA Capital Management, L.P. | 4,397,368 9.600% |
40,736 (+0.94%) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Lynx1 Capital Management LP | 3,126,173 6.800% |
1,588,828 (+103.35%) |
Filing History |
| 2023-02-14 3:38 pm Sale |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Avidity Partners Management LP | 1,888,887 4.000% |
-316,800 (-14.36%) |
Filing History |
| 2023-02-13 5:57 pm Sale |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BIOTECHNOLOGY VALUE FUND L P | 1,353,815 2.900% |
-235,680 (-14.83%) |
Filing History |
| 2023-02-13 4:46 pm Unchanged |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Omega Fund VI, L.P. | 2,415,050 5.200% |
0 (Unchanged) |
Filing History |
| 2022-10-03 5:16 pm Purchase |
2022-09-23 | 13G | Alpine Immune Sciences, Inc. ALPN |
Paradigm BioCapital Advisors LP | 2,214,722 5.030% |
2,214,722 (New Position) |
Filing History |
| 2022-10-03 4:30 pm Purchase |
2022-09-21 | 13G | Alpine Immune Sciences, Inc. ALPN |
RA Capital Management, L.P. | 4,356,632 9.910% |
4,356,632 (New Position) |
Filing History |
| 2022-09-30 09:37 am Purchase |
2022-09-21 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 3,448,521 7.850% |
3,448,521 (New Position) |
Filing History |
| 2022-09-27 5:02 pm Purchase |
2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN |
Alpine ImmunoSciences L.P. | 3,905,590 8.600% |
237,292 (+6.47%) |
Filing History |
| 2022-09-27 4:29 pm Sale |
2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,081,592 9.300% |
-145,251 (-3.44%) |
Filing History |
| 2022-09-27 4:00 pm Purchase |
2022-09-23 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 7,974,207 17.600% |
2,010,246 (+33.71%) |
Filing History |
| 2022-04-22 4:26 pm Purchase |
2022-04-14 | 13G | Alpine Immune Sciences, Inc. ALPN |
Lynx1 Capital Management LP | 1,537,345 5.100% |
1,537,345 (New Position) |
Filing History |
| 2022-02-15 2:18 pm Sale |
2022-02-11 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 3,164,108 10.800% |
-13,734 (-0.43%) |
Filing History |
| 2022-02-14 3:21 pm Purchase |
2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Omega Fund VI, L.P. | 2,415,050 8.200% |
2,415,050 (New Position) |
Filing History |
| 2022-02-14 1:15 pm Purchase |
2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BIOTECHNOLOGY VALUE FUND L P | 1,589,495 5.400% |
451,731 (+39.70%) |
Filing History |
| 2022-02-14 11:53 am Purchase |
2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital Management III (Cayman) LLC | 4,708,288 16.110% |
4,708,288 (New Position) |
Filing History |
| 2022-02-11 8:18 pm Purchase |
2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Avidity Partners Management LP | 2,205,687 7.300% |
735,297 (+50.01%) |
Filing History |
| 2021-11-12 5:05 pm Purchase |
2021-11-10 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,226,843 14.400% |
1,010,637 (+31.42%) |
Filing History |
| 2021-09-21 5:04 pm Purchase |
2021-09-17 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 5,963,961 19.600% |
1,554,240 (+35.25%) |
Filing History |